Cargando…

Analysis of Ferroptosis-Related LncRNAs Signatures Associated with Tumor Immune Infiltration and Experimental Validation in Clear Cell Renal Cell Carcinoma

BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is the most aggressive subtype of renal cell carcinoma. Ferroptosis is an iron-dependent programmed cell death. Long non-coding RNAs (lncRNAs) emerge as a critical role in regulating cancer progression. OBJECTIVE: This study aimed to identify molec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Xinyi, Tu, Jingyao, Ma, Li, Huang, Yongbiao, Yang, Chunguang, Yuan, Xianglin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942346/ https://www.ncbi.nlm.nih.gov/pubmed/35342303 http://dx.doi.org/10.2147/IJGM.S354682

Ejemplares similares

Development and validation of ferroptosis-related lncRNAs prognosis signatures in kidney renal clear cell carcinoma
por: Xing, Xiao-Liang, et al.
Publicado: (2021)

A Prognostic Signature for Clear Cell Renal Cell Carcinoma Based on Ferroptosis-Related lncRNAs and Immune Checkpoints
por: Dong, Yunze, et al.
Publicado: (2022)

LncRNAs Expression Signatures of Renal Clear Cell Carcinoma Revealed by Microarray
por: Yu, Gan, et al.
Publicado: (2012)

Construction of a ferroptosis-related signature based on seven lncRNAs for prognosis and immune landscape in clear cell renal cell carcinoma
por: Wei, Shi-Yao, et al.
Publicado: (2022)

Development and Validation of Ferroptosis- and Immune-Related lncRNAs Signatures for Breast Infiltrating Duct and Lobular Carcinoma
por: Wei, Tao, et al.
Publicado: (2022)

Development and validation of ferroptosis-related lncRNAs signature for hepatocellular carcinoma
por: Liang, Jiaying, et al.
Publicado: (2021)

Bioinformatic Analyses of the Ferroptosis-Related lncRNAs Signature for Ovarian Cancer
por: Zheng, Jianfeng, et al.
Publicado: (2022)

Prognosis Signature of Cuprotosis-Related lncRNAs Associated with Kidney Renal Clear Cell Carcinoma
por: Gao, Yiren, et al.
Publicado: (2022)

A Ferroptosis-Related lncRNAs Signature Predicts Prognosis of Colon Adenocarcinoma
por: Guo, Ying, et al.
Publicado: (2023)

A novel necroptosis-related lncRNAs signature for survival prediction in clear cell renal cell carcinoma
por: Zhao, Liwen, et al.
Publicado: (2022)

Identification of Five Ferroptosis-Related LncRNAs as Novel Prognosis and Diagnosis Signatures for Renal Cancer
por: Shu, Xiangjun, et al.
Publicado: (2022)

A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma
por: Jiang, Wen, et al.
Publicado: (2019)

Ferroptosis-related lncRNAs signature to predict the survival and immune evasion for lung squamous cell carcinoma
por: Zhang, Rusi, et al.
Publicado: (2022)

Development and validation of a ferroptosis-related lncRNAs prognosis signature in colon cancer
por: Cai, Hua-jun, et al.
Publicado: (2021)

The clinical significance, immune infiltration, and tumor mutational burden of angiogenesis-associated lncRNAs in kidney renal clear cell carcinoma
por: Zhang, Wei, et al.
Publicado: (2022)

Computational construction of TME‐related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma
por: Zhou, Libin, et al.
Publicado: (2022)

A Cuproptosis-Related lncRNAs Signature Could Accurately Predict Prognosis in Patients with Clear Cell Renal Cell Carcinoma
por: Zhang, Wei, et al.
Publicado: (2022)

A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer
por: Zhang, Kaiming, et al.
Publicado: (2021)

A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Therapeutic Response of Gastric Cancer
por: Xiao, Shilang, et al.
Publicado: (2021)

Development and validation of a ferroptosis-related lncRNAs signature to predict prognosis and microenvironment for melanoma
por: Ping, Shuai, et al.
Publicado: (2022)

Identification and Verification of Immune Subtype-Related lncRNAs in Clear Cell Renal Cell Carcinoma
por: Wang, Zhifeng, et al.
Publicado: (2022)

LncRNAs regulate ferroptosis to affect diabetes and its complications
por: Chen, Qianqian, et al.
Publicado: (2022)

Cuproptosis-related LncRNAs signature as biomarker of prognosis and immune infiltration in pancreatic cancer
por: Chen, Hui, et al.
Publicado: (2023)

A Prognostic Ferroptosis-Related lncRNAs Signature Associated With Immune Landscape and Radiotherapy Response in Glioma
por: Zheng, Jianglin, et al.
Publicado: (2021)

Identification and validation of the clinical roles of the VHL-related LncRNAs in clear cell renal cell carcinoma
por: Yang, Wuping, et al.
Publicado: (2021)

Discovery and validation of the prognostic value of the lncRNAs encoding snoRNAs in patients with clear cell renal cell carcinoma
por: Yang, Wuping, et al.
Publicado: (2020)

LncRNAs in Stem Cells
por: Hu, Shanshan, et al.
Publicado: (2016)

A Novel Pyroptosis-Related lncRNAs Signature for Predicting the Prognosis of Kidney Renal Clear Cell Carcinoma and Its Associations with Immunity
por: Tang, Xinfang, et al.
Publicado: (2021)

Close interactions between lncRNAs, lipid metabolism and ferroptosis in cancer
por: Huang, Jingjing, et al.
Publicado: (2021)

Ferroptosis-related lncRNAs guiding osteosarcoma prognosis and immune microenvironment
por: Yang, Mingyi, et al.
Publicado: (2023)

Construction and experimental validation of a signature for predicting prognosis and immune infiltration analysis of glioma based on disulfidptosis-related lncRNAs
por: Guo, Youwei, et al.
Publicado: (2023)

Identification and Validation of Ferroptosis-Related LncRNAs Signature as a Novel Prognostic Model for Chronic Lymphocytic Leukemia
por: Xu, Zhangdi, et al.
Publicado: (2023)

Comprehensive analysis of lncRNAs as biomarkers for diagnosis, prognosis, and treatment response in clear cell renal cell carcinoma
por: Chao, Xiaoyu, et al.
Publicado: (2021)

Integrated Bioinformatics Analysis for the Identification of Key lncRNAs, mRNAs, and Potential Drugs in Clear Cell Renal Cell Carcinomas
por: Liu, Sheng, et al.
Publicado: (2023)

Epitranscriptomic Signatures in lncRNAs and Their Possible Roles in Cancer
por: Dinescu, Sorina, et al.
Publicado: (2019)

A ceRNA Network Composed of Survival-Related lncRNAs, miRNAs, and mRNAs in Clear Cell Renal Carcinoma
por: Lu, Wenjun, et al.
Publicado: (2022)

Identification of a Ferroptosis-Related Signature Model Including mRNAs and lncRNAs for Predicting Prognosis and Immune Activity in Hepatocellular Carcinoma
por: Chen, Zi-An, et al.
Publicado: (2021)

A Novel Ferroptosis-Related lncRNAs Signature Predicts Clinical Prognosis and Is Associated With Immune Landscape in Pancreatic Cancer
por: Ping, Haiqin, et al.
Publicado: (2022)

A comprehensive prognostic and immunological analysis of telomere-related lncRNAs in kidney renal clear cell carcinoma
por: Chen, Ji, et al.
Publicado: (2023)

Development and Interpretation of a Genomic Instability Derived lncRNAs Based Risk Signature as a Predictor of Prognosis for Clear Cell Renal Cell Carcinoma Patients
por: Yang, Huiying, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_02lke380p8ji3lah1j15qjcrjb